Business description: OrganiGram
Sales by Activity: OrganiGram
| Fiscal Period: September | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Production and Sale of Cannabis | 79.16M | 146M | 162M | 160M | 259M |
Geographical breakdown of sales: OrganiGram
| Fiscal Period: September | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Canada | 109M | 194M | 215M | 237M | 377M |
International | 386K | 15.14M | 18.87M | 9.65M | 26.34M |
Unallocated | -30.49M | -63.18M | -71.95M | -87.24M | -144M |
Executive Committee: OrganiGram
| Manager | Title | Age | Since |
|---|---|---|---|
James Yamanaka
CEO | Chief Executive Officer | - | 2026-01-14 |
Greg Guyatt
DFI | Director of Finance/CFO | - | 2024-01-07 |
Borna Zlamalik
CTO | Chief Tech/Sci/R&D Officer | - | - |
Max Schwartz
IRC | Investor Relations Contact | - | 2023-01-31 |
Bradley Gunter
SAM | Sales & Marketing | - | 2025-04-30 |
Composition of the Board of Directors: OrganiGram
| Director | Title | Age | Since |
|---|---|---|---|
Peter Amirault
CHM | Chairman | 65 | 2018-03-28 |
Dexter John
BRD | Director/Board Member | 56 | 2018-12-16 |
Sherry Porter
BRD | Director/Board Member | 70 | 2018-12-16 |
Geoffrey Machum
BRD | Director/Board Member | 66 | 2020-02-24 |
Stephen Smith
BRD | Director/Board Member | 68 | 2020-02-24 |
| Director/Board Member | 63 | 2021-01-11 | |
Simon Ashton
BRD | Director/Board Member | 57 | 2022-02-22 |
Karina Gehring
BRD | Director/Board Member | - | 2024-01-17 |
Craig Harris
BRD | Director/Board Member | - | 2024-07-28 |
James Yamanaka
BRD | Director/Board Member | - | 2026-01-14 |
Company details: OrganiGram
Medical Farming
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +72.76% | -.--% | -43.36% | - | 578M | |
| +2.60% | -3.43% | +48.12% | +215.45% | 225M | |
| 0.00% | +5.49% | +10.34% | +113.33% | 135M | |
| -3.56% | -2.95% | +13.02% | -10.52% | 86.67M | |
| 0.00% | -3.45% | +9.09% | -39.13% | 85.25M | |
| -0.14% | -7.80% | -44.16% | -52.17% | 51.26M | |
| Average | +11.94% | -2.02% | -1.16% | +45.39% | 193.59M | |
| Weighted average by Cap. | +36.43% | -0.84% | -11.34% | +97.53% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
